Roche’s injectable Herceptin formula endorsed by the EU

Roche has won EU approval for a new injectable formula of its breast cancer drug, Herceptin, to treat the HER2-positive type of the disease.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news